Protein-losing enteropathy in inflammatory bowel diseases

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Science

Background:

• Protein-losing enteropathy (PLE) is an infrequent complication in patients diagnosed with inflammatory bowel diseases (IBDs).
• It should be suspected in patients with hypoproteinemia when other causes like hepatic disease, malnutrition, or proteinuria are ruled out.

Purpose of the Study:

• To discuss the diagnostic approaches for PLE in IBD patients.
• To outline the prognostic factors and therapeutic strategies for managing this complication.

Main Methods:

• Diagnosis is established by measuring fecal alpha-1 antitrypsin clearance and analyzing stool samples.
• Prognosis is evaluated based on individual patient factors, disease location, severity, and complications.

Main Results:

• Treatment strategies are multifaceted, including controlling the underlying IBD, albumin infusions for severe hypoalbuminemia, nutritional support, and preventative care for complications such as deep vein thrombosis.
• While surgery is not curative for Crohn's disease, it may be considered for severe, refractory PLE.

Conclusions:

• Early consideration and appropriate diagnostic workup are crucial for identifying PLE in IBD patients.
• Comprehensive management, tailored to the individual, is essential for improving outcomes in patients with IBD-associated PLE.